| 杨会欣,魏淑彦,贾立云,李天洁,文晓燕,潘雪娇.妊娠相关蛋白A、过氧化物酶体增殖物激活受体-γ基因多态性与子痫前期的易感性和妊娠结局的关系研究[J].,2023,(13):2572-2577 |
| 妊娠相关蛋白A、过氧化物酶体增殖物激活受体-γ基因多态性与子痫前期的易感性和妊娠结局的关系研究 |
| Relationship Study between Pregnancy-Associated Protein A and Peroxisome Proliferator-Activated Receptor-γ Gene Polymorphisms and Preeclampsia Susceptibility and Pregnancy Outcomes |
| 投稿时间：2023-01-05 修订日期：2023-01-26 |
| DOI：10.13241/j.cnki.pmb.2023.13.035 |
| 中文关键词: 子痫前期 妊娠相关蛋白A 过氧化物酶体增殖物激活受体-γ 基因多态性 妊娠结局 |
| 英文关键词: Preeclampsia Pregnancy associated protein A Peroxisome proliferator-activated receptor-γ Gene polymorphism Pregnancy outcomes |
| 基金项目:河北省卫健委指导性科技计划项目（20221656） |
|
| 摘要点击次数: 285 |
| 全文下载次数: 198 |
| 中文摘要: |
| 摘要 目的：探讨妊娠相关蛋白A（PAPP-A）、过氧化物酶体增殖物激活受体-γ（PPAR-γ）基因多态性与子痫前期（PE）的易感性和妊娠结局的关系。方法：选取2018年7月至2021年6月石家庄妇幼保健院收治的125例PE患者（PE组）及125例本院同期产检健康孕妇（对照组），统计并对比两组临床结局，根据PE患者妊娠结局的不同分为不良组和良好组。检测所有研究对象外周血脱氧核糖核酸（DNA）样本中PAPP-A、PPAR-γ基因单核苷酸多态性（SNP）位点，并对比PE组与对照组、良好组与不良组SNP位点基因型及等位基因频率，并分析其与PE及PE不良妊娠结局发生的关系。结果：PE组与对照组PPAR-γ基因rs10865710、rs4684847位点及PAPP-A基因rs7020782位点的基因型分布比较有统计学差异，且PE组PPAR-γ基因rs10865710等位基因G、rs4684847等位基因T及PAPP-A基因rs7020782等位基因C频率高于对照组（P＜0.05）；二分类Logistic回归分析显示，PPAR-γ基因rs10865710位点GG基因型（OR=2.641）及G等位基因（OR=1.641）、PPAR-γ基因rs4684847位点CT基因型（OR=3.084）及T等位基因（OR=2.985）、PAPP-A基因rs7020782位点CC基因型（OR=2.104）及C等位基因（OR=1.875）均是PE发生的危险因素（P＜0.05）。PE组总不良妊娠结局发生率为33.60%，显著高于对照组的5.60%（P＜0.05）。不良组与良好组PPAR-γ基因rs10865710、rs4684847位点及PAPP-A基因rs7020782位点的基因型分布比较有统计学差异，且不良组PPAR-γ基因rs10865710等位基因G、rs4684847等位基因T、PAPP-A基因rs7020782等位基因C频率高于良好组（P＜0.05）；二分类Logistic回归分析显示，PPAR-γ基因rs10865710位点GG基因型（OR=2.446）及G等位基因（OR=1.503）、PPAR-γ基因rs4684847位点CT基因型（OR=2.225）及T等位基因（OR=2.013）、PAPP-A基因rs7020782位点CC基因型（OR=2.005）及C等位基因（OR=1.950）均是不良妊娠结局的危险因素（P＜0.05）。结论：PPAR-γ基因rs10865710、rs4684847位点及PAPP-A基因rs7020782位点可能与PE易感性及PE不良妊娠结局的发生有关，检测两个基因的SNP位点可能有助于评估PE及其不良妊娠结局的发生风险。 |
| 英文摘要: |
| ABSTRACT Objective: To investigate the relationship between pregnancy-associated protein A (PAPP-A) and peroxisome proliferator-activated receptor-γ (PPAR-γ) gene polymorphisms and preeclampsia (PE) susceptibility and pregnancy outcomes. Methods: 125 PE patients (PE group) who were admitted to Shijiazhuang Maternal and Child Health Hospital from July 2018 to June 2021 and 125 healthy pregnant women (control group) who were were examined during the same period were selected. The clinical outcomes in the two groups were statistically analyzed and compared. According to the different pregnancy outcomes of PE patients, they were divided into poor group and good group. The single nucleotide polymorphism (SNP) sites of PAPP-A and PPAR-γ genes in peripheral blood deoxyribonucleic acid (DNA) samples of all subjects were detected, and the SNP genotype and allele frequency in the PE group and control group, good group and poor group were compared, and their relationship with PE and adverse pregnancy outcomes of PE were analyzed. Results: The genotype distribution of PPAR-γ gene rs10865710 and rs4684847 locus and PAPP-A gene rs7020782 locus were significantly different between the PE group and control group. The frequencies of PPAR-γ gene rs10865710 allele G, rs4684847 allele T and PAPP-A gene rs7020782 allele C in the PE group were higher than those in the control group (P<0.05). Binary Logistic regression analysis showed that PPAR-γ gene rs10865710 GG genotype (OR=2.641) and G allele (OR=1.641), PPAR-γgene rs4684847 CT genotype (OR=3.084) and T allele (OR=2.985), PAPP-A gene rs7020782 locus CC genotype (OR=2.104) and C allele (OR=1.875) were risk factors for PE occurrence (P<0.05). The incidence of total adverse pregnancy outcomes in the PE group was 33.60%, which was significantly higher than 5.60% in the control group(P<0.05). The genotype distribution of rs10865710 and rs4684847 locus of PPAR-γgene and rs7020782 of PAPP-A gene locus in the poor group and good group were statistically different, the frequency of PPAR-γgene rs10865710 allele G, rs4684847 allele T and PAPP-A gene rs7020782 allele C in the poor group were higher than those in the good group (P<0.05). Binary Logistic regression analysis showed that PPAR-γgene rs10865710 GG genotype (OR=2.446) and G allele (OR=1.503), PPAR-γgene rs4684847 CT genotype (OR=2.225) and T allele (OR=2.013), PAPP-A gene rs7020782 locus CC genotype (OR=2.005) and C allele (OR=1.950) were risk factors for adverse pregnancy outcomes(P<0.05). Conclusion: The rs10865710 and rs4684847 locus of PPAR-γgene and rs7020782 locus of PAPP-A gene may be associated with PE susceptibility and adverse pregnancy outcomes of PE. Detection of SNP locus of these two genes may be helpful to evaluate the risk of PE and adverse pregnancy outcomes. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
